Diabetes Australia is governed by a Board and is chaired by an independent President and Directors from our member organisations. Currently the Board is led by the Honourable Judi Moylan as the Diabetes Australia President.
Current Board members:
Hon Judi Moylan AO- Independent President and Board Chair
- Ms Tracy Aylen
- Mr Craig Beyers
- Mr Chris Jose
- Mr Robert Manning
- Ms Giuliana Murfet
- Mr John Townend AM
- Mr Leo Tutt
- Dr Moira Watson
- Associate Professor Paul Williams
- Professor Sophia Zoungas
Read more about the Board and Directors
Chief Executive Officer
Professor Greg Johnson
Greg Johnson joined Diabetes Victoria as Chief Executive in January 2003. He was Acting Chief Executive of Diabetes Australia from July 2009 to February 2011 and was appointed permanently in November 2012.
He has over 25 years experience in healthcare leadership in CEO and Board roles and has lived and worked in NSW, Victoria, SA and Tasmania.
He is an Adjunct Professor with Deakin University and holds a degree in pharmacy, post-graduate qualifications in hospital pharmacy and health service management, and a masters degree in business administration.
He has participated in a wide range of health industry and government advisory committees and has a particular interest in prevention and has led the establishment of a number of leading diabetes prevention initiatives. Greg is also a passionate advocate for people affected by diabetes and raising awareness of the seriousness and impact of diabetes on the health and productivity of Australia.
Senior Management Team
- General Manager, Corporate Services - Paul Southcott
- General Manager, NDSS - Susan Davidson
- Director, National Policy and Program Director- Taryn Black
- Director, Corporate Partnerships and Philanthropy - Joanne Beckett
Diabetes Australia Committees
Diabetes Australia Board Committees provide assistance and assurance to the Board of Directors in fulfilling its corporate governance and oversight responsibilities. These committees include:
The Finance & Audit and Risk Management Committee (FARM) provides assistance to the Board of Directors in fulfilling its corporate governance and oversight responsibilities in relation to the Company's financial reporting, internal control structure, risk management systems, external audit functions and compliance and external accounting responsibilities.
The Medical, Education and Scientific Council (MESC) provides advice to the Board on relevant medical, education and scientific matters.
The International Affairs Committee (IAC) provides advice to the Board on matters related to the International Diabetes Federation (IDF) and global activities related to diabetes.
The NDSS Governance Committee provides advice, assistance and assurance to the Board on corporate governance and oversight responsibilities in respect to Diabetes Australia's NDSS agreements.
Nomination and Remuneration Committee recommends candidates for key roles (CEO and Independent President) alongside remuneration and terms and conditions of employment.
Parliamentary Friends of Diabetes
In 2000, the Hon. Judi Moylan MP established the Parliamentary Friends of Diabetes Group with bi-partisan support from executive members Dr Mal Washer MP and the Hon. Dick Adams MP, with former members Mr Cameron Thompson and Mr Guy Barnett (former Senator for Tasmania).
Upon retiring from Parliament in 2013, the Hon. Judi Moylan has become President of Diabetes Australia.
The Parliamentary Friends of Diabetes Group was established to:
- Raise awareness of diabetes types 1 and 2 among Members of Parliament and staff
- Act as a conduit to Ministers to improve policy responses to management, education and research
- Offer support to Members, Senators and staff working Parliament House who have been diagnosed with diabetes
- Liaise with industry groups, research organisations and allied health professionals
- Promote the development of public policies and increase public awareness and knowledge of comprehensive management regimes
- Host or co-host a minimum of two events each year to highlight the public health risks of the diabetes epidemic
- Draw world-wide attention to the complications and quality of life implications and the effect on health budgets if governments do not act
- Encourage all parliaments to establish support groups.